Lutein and astaxanthin as dietary support of therapy
Postepy Fitoterapii
; 1:33-39, 2022.
Article
Dans Polonais
| CAB Abstracts | ID: covidwho-1975716
ABSTRACT
Lutein and astaxanthin belong to carotenoids which have wide applications in food, nutraceutical and pharmaceutical industries. The total chemical syntheses of lutein and astaxanthin produces a mixture of stereoisomers. Both carotenoids are extracted from the plant material as the mixture of mono- and diesters. Lutein is extracted from marigold and tagetes flowers. Lutein supplementation increases its concentration in blood serum and in the macula of the eye. There is increasing evidence that lutein is important in the prevention of age-related macular degeneration (AMD) and may improve eye health. Astaxanthin is extracted from the Haematococcus pluvialis algae. Due to its strong antioxidant, anti-inflammatory, and immunomodulatory properties, they can be used to support the treatment of neurodegenerative and cardiovascular diseases, diabetes, eye diseases, and to supplement the diet of COVID-19 patients.
Animal Models of Human Nutrition [VV140]; Composition and Quality of Non-food/Non-feed Plant Products [SS230]; Other Produce [QQ070]; xanthophyll; astaxanthin; antioxidants; cardiovascular diseases; carotenoids; diabetes; inflammation; macular degeneration; mixtures; terpenoids; xanthophylls; immunomodulatory properties; antioxidant properties; antiinflammatory properties; Haematococcus pluvialis; man; Haematococcus; Haematococcaceae; Chlorophyta; algae; plants; eukaryotes; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; lutein; tetraterpenoids; maculopathy; terpenes; anti-oxidant properties; radical scavenging properties; anti-inflammatory properties
Texte intégral:
Disponible
Collection:
Bases de données des oragnisations internationales
Base de données:
CAB Abstracts
langue:
Polonais
Revue:
Postepy Fitoterapii
Année:
2022
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS